50 Years of Double Helix
Vanemuise Concert Hall - September 12-13, 2003
-   Overview   -   Speakers   -   Programme   -   Biobusiness workshop   -   Bioethics workshop   -   Exhibition   -   Participants   -   Links  
eesti keeles

Organized by:

estonian genome fundation
estonian biocentre
EC projects GENEMILL and
EL flag

tartu ülikool
british embassy
british council

Official Carrier:
estonian air


  Estonian Genome

  tel. +372 7 420 132
  fax +372 7 440 421
- -
- - -

Keynote Speakers

Prof. Rolf M. Zinkernagel,
Nobel Prize (1996), Institute of Experimental Immunology, University of Zurich, Switzerland


Prof. Adriano Aguzzi,
Institute for Neuropathology, University of Zurich, Switzerland
Prof. Thomas Baldwin,
Department of Philosophy, University of York, UK Stem Cell Steering Committee, Nuffield Council of Bioethics, UK
Dr. Markus Beier,
Director Application, Intellectual Property Advisor, febit ag, Germany
Dr. Andrew Bergen,
Core Genotyping Facility, National Cancer Institute, USA
Dr. Anne Cambon-Thomsen,
Research Director, CNRS, Epidemiology and Analysis in Public Health Faculty of Medicine, INSERM, France
Estonian Genome Foundation,
Prof. Paolo Gasparini,
Associate Professor in Medical Genetics, Faculty of Medicine, Second University of Naples, Italy
Dr. Struan Grant,
DeCode Genetics, Reykjavik, Iceland
Prof. Pierre Hainaut,
Chief of Unit, Molecular Carcinogenesis, IARC, France
Prof. Magnus Ingelman-Sundberg,
Karolinska Institute, Stockholm, Sweden
Dr. Malle Jürima-Romet,
Director, Drug Development Programs, MDS Pharma Services, Montreal, Canada
Dr. Sulev Kõks,
Department of Physiology, University of Tartu, Estonia
Dr. Krista Kruuv,
Estonian Genome Project Foundation - Experience of the Year, Estonia
Prof. Toivo Maimets,
Minister, Ministry of Education and Research, Estonia
Dr. Duncan McHale,
Director and European Head of Clinical Pharmacogenomics, Sandwich Laboratories, Pfizer Ltd, UK
Dr. John Newton,
Chief Executive Officer, UK Biobank Project, United Kingdom
Prof. Torben Orntoft,
Molecular Diganostics laboratory, Department of Clinical Biocheministry, Åarhus University Hospital, Denmark
Leslie A. Platt, J.D.,
Principal&Leader, Health Sciences Research Compliance Group, Ernst&Young LLP, USA
Prof. Hannu Raunio,
University of Kuopio, Finland
Prof. Bo Samuelsson,
Chairman of ScanBalt, Vice-Chancellor of Göteborg University, Sweden
Dr. Ruth Taylor,
Sr. Marketing Manager,
IBM Life Sciences Information Based Medicine, USA
Prof. Rudi Westendorp,
Leiden University Medical Centre, Leiden, The Netherlands
Prof. Alan Wright,
Cell and Molecular Genetics Section, MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK
Dr. Martin Yuille,
Chief Scientist, MRC geneservice, United Kingdom